2025 annual financial data

Xenetic Biosciences 2025 Net margin

Direct answer

Net margin was -90.07%.

Operating income was -2.83M USD and net income was -2.68M USD.
Operating cash flow was -2.29M USD.

Get free Xenetic Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2.98M USD
Operating income
-2.83M USD
Net income
-2.68M USD
Operating cash flow
-2.29M USD